Genentech’s Actemra Receives FDA Authorization for COVID-19 Treatment
The FDA has granted an Emergency Use Authorization (EUA) which enables the treatment of COVID-19 in hospitalized adult and pediatric
Read moreThe FDA has granted an Emergency Use Authorization (EUA) which enables the treatment of COVID-19 in hospitalized adult and pediatric
Read moreAleta Biotherapeutics (‘Aleta’) and Cancer Research UK today announced a partnership to advance the early phase clinical development of Aleta’s
Read moreKite, a Gilead Company, and Shoreline Biosciences have announced a $2.3 Billion strategic partnership to develop novel cell therapies across
Read moreThe legal dispute between the British-Swedish biopharmaceutical giant AstraZeneca and the European Union over a contract to deliver COVID-19 vaccines
Read moreSingle-step purification and optimized reaction chemistry enable SARS-CoV-2 PCRwithin ~70 minutes. A BioEcho Life Sciences Case Study Laboratory-based polymerase chain
Read moreSARS-CoV-2 PCR’s Without RNA Extraction With the CE-IVD approved Volcano3G® Direct COVID-19 Kit diagnostic labs can completely skip the time-consuming
Read moreThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the Pfizer-BioNTech vaccine in children aged 12-15
Read moreDanish multinational pharmaceutical company Novo Nordisk and Japanese cardiac regenerative medicine specialist Heartseed have confirmed an exclusive global partnership and license
Read moreGSK and Vir Biotechnology announced that the monoclonal antibody sotrovimab (VIR-7831) has received Emergency Use Authorization (EUA) from the US
Read moreThe United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has authorized use of the Janssen single-dose COVID-19 vaccine. The
Read more